A Study Evaluating the Efficacy and Safety of Adjuvant Platinum-Doublet Chemotherapy, With or Without Atezolizumab, in Patients Who Are ctDNA Positive After Complete Surgical Resection of Stage IB to Select IIIB Non-Small Cell Lung Cancer
Clinical trial NCT04611776 · WITHDRAWN
Trial details
- NCT number
- NCT04611776
- Sponsor
- Hoffmann-La Roche
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2025-03-06
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.